Tau protein kinases: Involvement in Alzheimer's disease

Martin, Ludovic, Latypova, Xenia, Wilson, Cornelia M., Magnaudeix, Amandine, Perrin, Marie-Laure, Yardin, Catherine, Terro, Faraj·2013·Ageing Research Reviews
DOI 10.1016/j.arr.2012.06.003

Cited by (646)

Items 101–200 of 646

  1. Gracilins: Spongionella-derived promising compounds for Alzheimer disease
    Marta Leirós, Eva Alonso, Mostafa Ezzat Rateb, Wael E. Houssen, Rainer Ebel, Marcel Jaspars, Amparo Alfonso, Luis Miguel Botana · 2015 · Neuropharmacology
  2. Characterization of Neuronal Tau Protein as a Target of Extracellular Signal-regulated Kinase
    Haoling Qi, Sudhakaran Prabakaran, François‐Xavier Cantrelle, Béatrice Chambraud, Jeremy Gunawardena, Guy M. Lippens, Isabelle Landrieu · 2016 · Journal of Biological Chemistry
  3. The Crocus sativus Compounds trans-Crocin 4 and trans-Crocetin Modulate the Amyloidogenic Pathway and Tau Misprocessing in Alzheimer Disease Neuronal Cell Culture Models
    Ioanna Chalatsa, D. Arvanitis, N. Koulakiotis, A. Giagini, A. Skaltsounis, Z. Papadopoulou-Daifoti, A. Tsarbopoulos, D. Sanoudou · 2019 · Frontiers in Neuroscience
  4. Nutraceuticals: An emerging therapeutic approach against the pathogenesis of Alzheimer’s disease
    Pritam Sadhukhan, Sukanya Saha, Sayanta Dutta, Sushweta Mahalanobish, Parames Chandra Sil · 2017 · Pharmacological Research
  5. Design, biological evaluation and X-ray crystallography of nanomolar multifunctional ligands targeting simultaneously acetylcholinesterase and glycogen synthase kinase-3
    Killian Oukoloff, Nicolas Coquelle, Manuela Bartolini, Marina Naldi, Rémy Le Guével, Stéphane Bach, Béatrice Josselin, Sandrine Ruchaud, Marco Catto, Leonardo Pisani et al. · 2019 · European Journal of Medicinal Chemistry
  6. Novel Anti-Alzheimer’s Therapeutic Molecules Targeting Amyloid Precursor Protein Processing
    Md. Sahab Uddin, Md. Tanvir Kabir, Philippe Jeandet, Bijo Mathew, Ghulam Md Ashraf, Asma Perveen, May Nasser Bin-Jumah, Shaker A. Mousa, Mohamed M. Abdel‐Daim · 2020 · Oxidative Medicine and Cellular Longevity
  7. The protein serine/threonine phosphatases PP2A, PP1 and calcineurin: A triple threat in the regulation of the neuronal cytoskeleton
    Alexander Hoffman, Goce Taleski, Estelle Sontag · 2017 · Molecular and Cellular Neuroscience
  8. β-Amyloid Induces Pathology-Related Patterns of Tau Hyperphosphorylation at Synaptic Terminals
    Hsin‐Yi Wu, Po-Cheng Kuo, Yi-Ting Wang, Hao-Tai Lin, Allyson D. Roe, Bo Y. Wang, Chia‐Li Han, Bradley T. Hyman, Yu‐Ju Chen, Hwan‐Ching Tai · 2018 · Journal of Neuropathology & Experimental Neurology
  9. The Enigma of Tau Protein Aggregation: Mechanistic Insights and Future Challenges
    Huiting Zheng, Huimin Sun, Qixu Cai, Hwan‐Ching Tai · 2024 · International Journal of Molecular Sciences
  10. Review on anti-alzheimer drug development: approaches, challenges and perspectives
    Abdallah E. Abdallah · 2024 · RSC Advances
  11. The treatment of Alzheimer's disease using Chinese Medicinal Plants: From disease models to potential clinical applications
    Yang Su, Qiuhong Wang, Changfu Wang, Kelvin Chan, Yanping Sun, Haixue Kuang · 2014 · Journal of Ethnopharmacology
  12. Amyloid-β: A double agent in Alzheimer's disease?
    Yu, Hao, Wu, Jie · 2021 · Biomedicine & Pharmacotherapy
  13. Identification of novel small molecules against GSK3β for Alzheimer's disease using chemoinformatics approach
    Rohit Shukla, Nupur S. Munjal, Tiratha Raj Singh · 2019 · Journal of Molecular Graphics and Modelling
  14. A preclinical perspective on the enhanced vulnerability to Alzheimer's disease after early-life stress
    Lianne Hoeijmakers, Sylvie L. Lesuis, Harm J. Krugers, Paul John Lucassen, Anikó Kőrösi · 2018 · Neurobiology of Stress
  15. The Molecular Mechanisms of Neuroinflammation in Alzheimer’s Disease, the Consequence of Neural Cell Death
    Su-Bin Choi, Sehee Kwon, Ji-Hye Kim, Na-Hyun Ahn, Joo-Hee Lee, Seung‐Hoon Yang · 2023 · International Journal of Molecular Sciences
  16. The Role of Cholesterol Metabolism in Alzheimer’s Disease
    Sun, Jia-Hao, Yu, Jin-Tai, Tan, Lan · 2015 · Molecular Neurobiology
  17. Recent Advances in Electrochemical Aptasensors for Detection of Biomarkers
    Marjan Majdinasab, Jean‐Louis Marty · 2022 · Pharmaceuticals
  18. A positive feedback inhibition of isocitrate dehydrogenase 3β on paired-box gene 6 promotes Alzheimer-like pathology
    Xin Wang, Qian Liu, Haitao Yu, Jiazhao Xie, Junning Zhao, Zhi-Ting Fang, Min Qu, Yao Zhang, Ying Yang, Jian–Zhi Wang · 2024 · Signal Transduction and Targeted Therapy
  19. Cellular factors modulating the mechanism of tau protein aggregation
    Sarah N. Fontaine, Jonathan J. Sabbagh, Jeremy D. Baker, Carlos R. Martinez Licha, April L. Darling, Chad A. Dickey · 2015 · Cellular and Molecular Life Sciences
  20. Melatonin directly binds and inhibits death‐associated protein kinase 1 function in Alzheimer’s disease
    Dongmei Chen, Yingxue Mei, Nami Kim, Guihua Lan, Chen‐Ling Gan, Fei Fan, Tao Zhang, Yongfang Xia, Long Wang, Chun Lin et al. · 2020 · Journal of Pineal Research
  21. Akt signaling pathway: a potential therapy for Alzheimer’s disease through glycogen synthase kinase 3 beta inhibition
    Joshua Limantoro, Bryan Gervais de Liyis, Jane Carissa Sutedja · 2023 · The Egyptian Journal of Neurology Psychiatry and Neurosurgery
  22. Synthesis and molecular modelling studies of 8-arylpyrido[3′,2′:4,5]thieno[3,2-d]pyrimidin-4-amines as multitarget Ser/Thr kinases inhibitors
    Yvonnick Loidreau, Emmanuel Deau, Pascal Marchand, Marie‐Renée Nourrisson, Cédric Logé, Gaël Coadou, Nadège Loaëc, Laurent Meijer, Thierry Besson · 2014 · European Journal of Medicinal Chemistry
  23. Association between Alzheimer’s Disease and Oral and Gut Microbiota: Are Pore Forming Proteins the Missing Link?
    Sebastian D Aguayo, Christina Maria Anna Pia Schuh, Benjamín Vicente, Luis Gerardo Aguayo · 2018 · Journal of Alzheimer s Disease
  24. Anti-herpetic tau preserves neurons via the cGAS-STING-TBK1 pathway in Alzheimer’s disease
    Vanesa R. Hyde, Chaoming Zhou, J R Muñóz y Fernández, Krishnashis Chatterjee, Pururav Ramakrishna, Amanda Lin, Gregory W. Fisher, Orhan T. Celiker, Jill Caldwell, Omer Bender et al. · 2025 · Cell Reports
  25. Genistein protects against amyloid‐beta‐induced toxicity in SH‐SY5Y cells by regulation of Akt and Tau phosphorylation
    Fernanda dos Santos Petry, Bárbara Paranhos Coelho, Mariana Maier Gaelzer, Fernando Kreutz, Fátima Theresinha Costa Rodrigues Guma, Christianne Gazzana Salbego, Vera Maria Treis Trindade · 2019 · Phytotherapy Research
  26. Screening of tau protein kinase inhibitors in a tauopathy-relevant cell-based model of tau hyperphosphorylation and oligomerization
    Hamad Yadikar, Isabel Torres, Gabrielle Aiello, Milin Kurup, Zhihui Yang, Fan Yu Lin, Firas H. Kobeissy, Richard A. Yost, Kevin Wang · 2020 · PLoS ONE
  27. Progress in Target Drug Molecules for Alzheimer's Disease
    Jiayang Xie, Ruirui Liang, Yan‐Jiang Wang, Junyi Huang, Xin Cao, Bing Niu · 2019 · Current Topics in Medicinal Chemistry
  28. Tau Phosphorylation in Female Neurodegeneration: Role of Estrogens, Progesterone, and Prolactin
    Daniel Muñoz-Mayorga, Christian Guerra‐Araiza, Luz Torner, Teresa Morales · 2018 · Frontiers in Endocrinology
  29. Phytochemicals targeting Alzheimer's disease via the AMP-activated protein kinase pathway, effects, and mechanisms of action
    Zheng Zhao, Jun Yan, Lei Huang, Xue Yang · 2024 · Biomedicine & Pharmacotherapy
  30. Small Surface, Big Effects, and Big Challenges: Toward Understanding Enzymatic Activity at the Inorganic Nanoparticle–Substrate Interface
    W. Russ Algar, Tiffany Jeen, Melissa Massey, William J. Peveler, Jérémie Asselin · 2018 · Langmuir
  31. Tau phosphorylation in a mouse model of temporal lobe epilepsy.
    Alves, Marianna, Kenny, Aidan, de Leo, Gioacchino, Beamer, Edward H., Engel, Tobias · 2019 · Frontiers in Aging Neuroscience
  32. A combinatorial native MS and LC-MS/MS approach reveals high intrinsic phosphorylation of human Tau but minimal levels of other key modifications
    Friedel Drepper, Jacek Biernat, Senthilvelrajan Kaniyappan, Helmut E. Meyer, Eva‐Maria Mandelkow, Bettina Warscheid, Eckhard Mandelkow� · 2020 · Journal of Biological Chemistry
  33. Inflammation: major denominator of obesity, Type 2 diabetes and Alzheimer’s disease-like pathology?
    Miroslava Kacířová, Anna Zmeškalová, Lucia Kořínková, Blanka Železná, Jaroslav Kuneš, Lenka Maletı́nská · 2020 · Clinical Science
  34. Computer-Aided Drug Design Applied to Marine Drug Discovery: Meridianins as Alzheimer’s Disease Therapeutic Agents
    Laura Llorach-Parés, Alfons Nonell‐Canals, Melchor Sánchez-Martínez, Conxita Àvila · 2017 · Marine Drugs
  35. Discovery of Selective, Substrate-Competitive, and Passive Membrane Permeable Glycogen Synthase Kinase-3β Inhibitors: Synthesis, Biological Evaluation, and Molecular Modeling of New C-Glycosylflavones
    Zhibin Liang, Qing X. Li · 2018 · ACS Chemical Neuroscience
  36. Design and Synthesis of Thiazolo[5,4-f]quinazolines as DYRK1A Inhibitors, Part I
    Alicia Foucourt, Damien Hédou, Carole Dubouilh‐Benard, Laurent Désiré, Anne-Sophie Casagrande, Bertrand Leblond, Nadège Loaëc, Laurent Meijer, Thierry Besson · 2014 · Molecules
  37. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case–Control Study
    Zhipeng Xu, Sulian Yang, Shi Zhao, Chenghong Zheng, Honghua Li, Yao Zhang, Rongxi Huang, Mengzhu Li, Yuan Gao, Shujuan Zhang et al. · 2016 · EBioMedicine
  38. Tau-directed approaches for the treatment of Alzheimer’s disease: focus on leuco-methylthioninium
    Seripa, Davide, Solfrizzi, Vincenzo, Imbimbo, Bruno P., Daniele, Antonio, Santamato, Andrea, Lozupone, Madia, Zuliani, Giovanni, Greco, Antonio, Logroscino, Giancarlo, Panza, Francesco · 2016 · Expert Review of Neurotherapeutics
  39. Pharmacotherapy of Alzheimer’s disease: an overview of systematic reviews
    Reza Majidazar, Erfan Rezazadeh‐Gavgani, Saeed Sadigh‐Eteghad, Amirreza Naseri · 2022 · European Journal of Clinical Pharmacology
  40. Phosphorylation regulates tau’s phase separation behavior and interactions with chromatin
    Lannah S. Abasi, Nesreen Elathram, Manasi Movva, Amar Deep, Kevin D. Corbett, Galia T. Debelouchina · 2024 · Communications Biology
  41. Design and Synthesis of Thiazolo[5,4-f]quinazolines as DYRK1A Inhibitors, Part II
    Alicia Foucourt, Damien Hédou, Carole Dubouilh‐Benard, Angélique Girard, Thierry Taverne, Anne-Sophie Casagrande, Laurent Désiré, Bertrand Leblond, Thierry Besson · 2014 · Molecules
  42. Nanomaterial-based Optical and Electrochemical Biosensors for Amyloid beta and Tau: Potential for early diagnosis of Alzheimer’s Disease
    Le Minh Tu Phan; Phan Le Minh Tu, Thi Xoan Hoang, Vo Thuy Anh Thu, Hoang Lan Pham, Hien T. Ngoc Le, Somasekhar R. Chinnadayyala, Jae Young Kim, Sang-Myung Lee, Won Woo Cho, Young Hyo Kim et al. · 2021 · Expert Review of Molecular Diagnostics
  43. Rapamycin Attenuated Zinc-Induced Tau Phosphorylation and Oxidative Stress in Rats: Involvement of Dual mTOR/p70S6K and Nrf2/HO-1 Pathways
    Chencen Lai, Zhuyi Chen, Yuanting Ding, Chen Qian, Songbai Su, Heng Liu, Ruiqing Ni, Zhi Tang · 2022 · Frontiers in Immunology
  44. Nature's toolbox against tau aggregation: An updated review of current research
    Sumaiya Khan, Md. Imtaiyaz Hassan, Mohammad Shahid, Asimul Islam · 2023 · Ageing Research Reviews
  45. Phosphorylation of Mutant Huntingtin at Serine 116 Modulates Neuronal Toxicity
    Erin E. Watkin, Nicolas Arbez, Elaine Waldron, Robert N. O’Meally, Tamara Ratovitski, Robert Norman Cole, Christopher A. Ross · 2014 · PLoS ONE
  46. Multitarget-directed resveratrol derivatives: anti-cholinesterases, anti-β-amyloid aggregation and monoamine oxidase inhibition properties against Alzheimer's disease
    Long-Fei Pan, Xiaobing Wang, Sai‐Sai Xie, Suyi Li, Lingyi Kong · 2014 · MedChemComm
  47. Caniferolide A, a Macrolide from Streptomyces caniferus, Attenuates Neuroinflammation, Oxidative Stress, Amyloid-Beta, and Tau Pathology in Vitro
    Rebeca Alvariño, Eva Alonso, Rodney Lacret, Daniel Oves‐Costales, Olga Genilloud, Fernando Reyes, Amparo Alfonso, Luis Miguel Botana · 2019 · Molecular Pharmaceutics
  48. Synthesis and biological evaluation of N-aryl-7-methoxybenzo[b]furo[3,2-d]pyrimidin-4-amines and their N-arylbenzo[b]thieno[3,2-d]pyrimidin-4-amine analogues as dual inhibitors of CLK1 and DYRK1A kinases
    Yvonnick Loidreau, Pascal Marchand, Carole Dubouilh‐Benard, Marie‐Renée Nourrisson, Muriel Duflos, Nadège Loaëc, Laurent Meijer, Thierry Besson · 2012 · European Journal of Medicinal Chemistry
  49. Phosphatases of α-synuclein, LRRK2, and tau: important players in the phosphorylation-dependent pathology of Parkinsonism
    Jean‐Marc Taymans, Veerle Baekelandt · 2014 · Frontiers in Genetics
  50. Marine-Derived Compounds with Anti-Alzheimer’s Disease Activities
    Salar Hafez Ghoran, Anake Kijjoa · 2021 · Marine Drugs
  51. Unveiling the Multitarget Anti-Alzheimer Drug Discovery Landscape: A Bibliometric Analysis
    Anna Sampietro, Francisco Javier Pérez-Areales, Paula Martínez, Elsa M. Arce, Carles Galdeano, Diego Muñoz‐Torrero · 2022 · Pharmaceuticals
  52. Mitochondria-Targeted Delivery Strategy of Dual-Loaded Liposomes for Alzheimer’s Disease Therapy
    Leysan A. Vasileva, Gulnara A. Gaynanova, Farida G. Valeeva, G. P. Belyaev, Irina V. Zueva, Kseniya Bushmeleva, Guzel Sibgatullina, Dmitry V. Samigullin, Alexandra Borisovna Vyshtakalyuk, Konstantin A Petrov et al. · 2023 · International Journal of Molecular Sciences
  53. Anorexigenic Lipopeptides Ameliorate Central Insulin Signaling and Attenuate Tau Phosphorylation in Hippocampi of Mice with Monosodium Glutamate-Induced Obesity
    Andrea Špolcová, Barbora Mikulášková, Martina Holubová, Veronika Pražienková, Zdeno Pirník, Jana Zemenová, Martin Haluzı́k, Blanka Železná, Marie‐Christine Galas, Lenka Maletı́nská · 2015 · Journal of Alzheimer s Disease
  54. Transgenic models of Alzheimer's disease: Better utilization of existing models through viral transgenesis
    Thomas L Platt, Valerie L. Reeves, Michael Paul Murphy · 2013 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  55. An Unusual Binding Model of the Methyl 9-Anilinothiazolo[5,4-f] quinazoline-2-carbimidates (EHT 1610 and EHT 5372) Confers High Selectivity for Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases
    A. Chaikuad, Julien Diharce, Martin Schröder, Alicia Foucourt, Bertrand Leblond, Anne-Sophie Casagrande, Laurent Désiré, Pascal Bonnet, Stefan Knapp, Thierry Besson · 2016 · Journal of Medicinal Chemistry
  56. Genistein attenuates amyloid-beta-induced cognitive impairment in rats by modulation of hippocampal synaptotoxicity and hyperphosphorylation of Tau
    Fernanda dos Santos Petry, Juliana Bender Hoppe, Caroline Peres Klein, Bernardo Gindri dos Santos, Régis Mateus Hözer, Felippo Bifi, Cristiane Matté, Christianne Gazzana Salbego, Vera Maria Treis Trindade · 2020 · The Journal of Nutritional Biochemistry
  57. Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer’s Disease
    Long Wang, Xindong Shui, Yuelin Diao, Duoting Chen, Ying Zhou, Tae Ho Lee · 2023 · International Journal of Molecular Sciences
  58. Death-associated protein kinase 1 as a therapeutic target for Alzheimer's disease
    Tao Zhang, Byeong Mo Kim, Tae Ho Lee · 2024 · Translational Neurodegeneration
  59. Cytoskeletal Proteins and Alzheimer’s Disease Pathogenesis: Focusing on the Interplay with Tau Pathology
    Gege Jiang, Guanfeng Xie, Xiaoyi Li, Jing Xiong · 2025 · Biomolecules
  60. Rab10 Phosphorylation is a Prominent Pathological Feature in Alzheimer’s Disease
    Tingxiang Yan, Luwen Wang, Ju Gao, Sandra L. Siedlak, Mikayla L. Huntley, Pichet Termsarasab, George L. Perry, Shu G. Chen, Xinglong Wang · 2018 · Journal of Alzheimer s Disease
  61. Isoorientin Inhibits Inflammation in Macrophages and Endotoxemia Mice by Regulating Glycogen Synthase Kinase 3β
    Yingui Li, Yijing Zhao, Xiaoqin Tan, Jiayan Liu, Yingkun Zhi, Lang Yi, Shasha Bai, Qun Du, Qing X. Li, Yan Dong · 2020 · Mediators of Inflammation
  62. Long Non-coding RNA: Insight Into Mechanisms of Alzheimer's Disease
    Zhen Lan, Yanting Chen, Jiali Jin, Yun Xu, Xiaolei Zhu · 2022 · Frontiers in Molecular Neuroscience
  63. Neuroimmune Tau Mechanisms: Their Role in the Progression of Neuronal Degeneration
    Nicole Cortés, V. Andrade, L. Guzmán-Martínez, M. Estrella, R. Maccioni · 2018 · International Journal of Molecular Sciences
  64. Mechanisms Associated with Type 2 Diabetes as a Risk Factor for Alzheimer-Related Pathology
    Men Su, Kambiz Nadéri, Nathalie Samson-Desvignes, Ihsen Youssef, Lívia Fülöp, Zsolt Bozsó, Serge Laroche, Benoı̂t Delatour, Sabrina Davis · 2019 · Molecular Neurobiology
  65. Prenatal noise stress aggravates cognitive decline and the onset and progression of beta amyloid pathology in a mouse model of Alzheimer's disease
    Zahra Jafari, Megan Okuma, Hadil Karem, Jogender Mehla, Bryan E Kolb, Majid H. Mohajerani · 2019 · Neurobiology of Aging
  66. TTBK2: A Tau Protein Kinase beyond Tau Phosphorylation
    Jung‐Chi Liao, T. Tony Yang, Rueyhung Roc Weng, Ching‐Te Kuo, Chih‐Wei Chang · 2015 · BioMed Research International
  67. Pα-syn* mitotoxicity is linked to MAPK activation and involves tau phosphorylation and aggregation at the mitochondria
    Diego Grassi, Natalia Diaz-Perez, Laura A. Volpicelli‐Daley, Corinne Ida Lasmézas · 2018 · Neurobiology of Disease
  68. Tau Related Pathways as a Connecting Link between Epilepsy and Alzheimer’s Disease
    Yam Nath Paudel, Efthalia Angelopoulou, Nigel C. Jones, Terence John O'Brien, Patrick Kwan, Christina Piperi, Iekhsan Othman, Mohd. Farooq Shaikh · 2019 · ACS Chemical Neuroscience
  69. Electrochemical aptamer-based nanobiosensors for diagnosing Alzheimer's disease: A review
    Masoud Negahdary, Lúcio Angnes · 2022 · Biomaterials Advances
  70. IFN‐γ promotes τ phosphorylation without affecting mature tangles
    Li, Andrew, Ceballos‐Diaz, Carolina, DiNunno, Nadia, Levites, Yona, Cruz, Pedro E., Lewis, Jada, Golde, Todd E., Chakrabarty, Paramita · 2015 · The FASEB Journal
  71. In vivo induction of membrane damage by β-amyloid peptide oligomers
    Carl Julien, Colson Tomberlin, Christine M. Roberts, Aumbreen Akram, Gretchen H. Stein, Michael A. Silverman, Christopher D. Link · 2018 · Acta Neuropathologica Communications
  72. Ferroptosis promotes microtubule-associated protein tau aggregation via GSK-3β activation and proteasome inhibition
    Shaohui Wang, Yao Xing Jiang, Yabo Liu, Qianhui Liu, Hongwei Sun, Mengjie Mei, Xiaomei Liao · 2022 · Molecular Neurobiology
  73. Invited review: Drug development for tauopathies
    Fiona Grüninger · 2014 · Neuropathology and Applied Neurobiology
  74. Gene expression variability and the analysis of large-scale RNA-seq studies with the MDSeq
    Di Ran, Zhongyin John Daye · 2017 · Nucleic Acids Research
  75. Alzheimer’s Disease Targeted Nano-Based Drug Delivery Systems
    G. Altinoglu, Terin Adalı · 2019 · Current Drug Targets
  76. HDAC6 ZnF UBP as the Modifier of Tau Structure and Function
    Abhishek Ankur Balmik, Hariharakrishnan Chidambaram, Abha Dangi, Udaya Kiran Marelli, Subashchandrabose Chinnathambi · 2020 · Biochemistry
  77. Golgin-84-associated Golgi fragmentation triggers tau hyperphosphorylation by activation of cyclin-dependent kinase-5 and extracellular signal-regulated kinase
    Qian Jiang, Lu Wang, Yang Guan, Hui Xu, Yi Niu, Li Han, Yuping Wei, Lin Li, Jiang Chu, Qun Wang et al. · 2013 · Neurobiology of Aging
  78. Mechanistic insights into the role of herpes simplex virus 1 in Alzheimer’s disease
    Feng, Shu, Liu, Yongzhen, Zhou, Yu, Shu, Zhenfeng, Cheng, Zhuxi, Brenner, Charles, Feng, Pinghui · 2023 · Frontiers in Aging Neuroscience
  79. Developmental Perfluorooctanesulfonic acid (PFOS) exposure as a potential risk factor for late-onset Alzheimer’s disease in CD-1 mice and SH-SY5Y cells
    Veronia Basaly, Jaunetta Hill, Syed Waseem Bihaqi, Emily Marques, Angela Lucas Slitt, Nasser H. Zawia · 2021 · NeuroToxicology
  80. Treponema denticola Induces Alzheimer-Like Tau Hyperphosphorylation by Activating Hippocampal Neuroinflammation in Mice
    Z. Tang, Xingqun Cheng, X. Su, Linrui Wu, Q. Cai, Hongle Wu · 2022 · Journal of Dental Research
  81. Cholesterol and Lipid Rafts in the Biogenesis of Amyloid-β Protein and Alzheimer's Disease
    George Anthony Pantelopulos, Conor B. Abraham, John E. Straub · 2024 · Annual Review of Biophysics
  82. Molecular mechanisms and therapeutic potential of lithium in Alzheimer’s disease: repurposing an old class of drugs
    Yanxin Shen, Meng Zhao, Panpan Zhao, Lingjie Meng, Yan Zhang, Guimei Zhang, Yezi Taishi, Li Sun · 2024 · Frontiers in Pharmacology
  83. Phenylpropanoids and Alzheimer's disease: A potential therapeutic platform
    Igri Kolaj, S. Imindu Liyanage, Donald Fredric Weaver · 2018 · Neurochemistry International
  84. Exogenous brain-derived neurotrophic factor attenuates cognitive impairment induced by okadaic acid in a rat model of Alzheimer's disease
    Aihua Xu, Yang Yang, Yongxin Sun, Chaodong Zhang · 2018 · Neural Regeneration Research
  85. HIF-1α Causes LCMT1/PP2A Deficiency and Mediates Tau Hyperphosphorylation and Cognitive Dysfunction during Chronic Hypoxia
    Lei Ling, Jun Feng, Gang Wu, Zhen Cheng Wei, Jian‐Zhi Wang, Bin Zhang, Rong Liu, Fei Liu, Xiaochuan Wang, Honglian Li · 2022 · International Journal of Molecular Sciences
  86. Novel lipid signaling pathways in Alzheimer's disease pathogenesis
    Phillip F. Giannopoulos, Yash B. Joshi, Domenico Praticò · 2013 · Biochemical Pharmacology
  87. 1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea, a Selective and Potent Dual Inhibitor of Soluble Epoxide Hydrolase and p38 Kinase Intervenes in Alzheimer’s Signaling in Human Nerve Cells
    Zhibin Liang, Bei Zhang, Meng Xu, Christophe H.P. Morisseau, Sung Hee Hwang, Bruce D. Hammock, Qing X. Li · 2019 · ACS Chemical Neuroscience
  88. Anticancer drugs repurposed for Alzheimer’s disease: a systematic review
    Antonio Ancidoni, Ilaria Bacigalupo, Giulia Remoli, Eleonora Lacorte, Paola Piscopo, Giulia Sarti, Massimo Corbo, Nicola Vanacore, Marco Canevelli · 2021 · Alzheimer s Research & Therapy
  89. New Possibilities in the Therapeutic Approach to Alzheimer’s Disease
    Julia Doroszkiewicz, Barbara Mroczko · 2022 · International Journal of Molecular Sciences
  90. α-synuclein and tau: interactions, cross-seeding, and the redefinition of synucleinopathies as complex proteinopathies
    Francisco Javier Padilla-Godínez, Eunice Ruth Vázquez-García, María Isabel Trujillo-Villagrán, Luis Oskar Soto-Rojas, Marcela Palomero‐Rivero, Omar Hernández-González, Francisco Pérez-Eugenio, Omar Collazo-Navarrete, Óscar Arias-Carrión, Magdalena Guerra‐Crespo · 2025 · Frontiers in Neuroscience
  91. Inhibition of Tau Aggregation by Three Aspergillus nidulans Secondary Metabolites: 2,ω-Dihydroxyemodin, Asperthecin, and Asperbenzaldehyde
    Smita Paranjape, Yi‐Ming Chiang, James F. Sanchez, Ruth Entwistle, Clay C. C. Wang, Berl R. Oakley, T.C. Gamblin · 2014 · Planta Medica
  92. What is strain in neurodegenerative diseases?
    Ye Tian, Lanxia Meng, Zhentao Zhang · 2019 · Cellular and Molecular Life Sciences
  93. Small molecule modulation of the p75 neurotrophin receptor inhibits multiple amyloid beta-induced tau pathologies
    Tao Yang, Kevin C Tran, Anne Y. Zeng, Stephen M. Massa, Frank M. Longo · 2020 · Scientific Reports
  94. Metal organic frameworks as advanced extraction adsorbents for separation and analysis in proteomics and environmental research
    Yonglei Wu, Haolin Chen, Yijie Chen, Nianrong Sun, Chunhui Deng · 2022 · Science China Chemistry
  95. Cellular and molecular mechanisms of pathological tau phosphorylation in traumatic brain injury: implications for chronic traumatic encephalopathy
    Neil S. Donison, Jacqueline Palik, Kathryn Volkening, Michael Joseph Strong · 2025 · Molecular Neurodegeneration
  96. Genetic Variants of GSK3B are Associated with Biomarkers for Alzheimer's Disease and Cognitive Function
    Petronella Kettunen, Susanna C. Larsson, Sandra Holmgren, Sandra Olsson, Lennart Minthon, Henrik Zetterberg, Kaj Blennow, Staffan Nilsson, Annica Sjölander · 2015 · Journal of Alzheimer s Disease
  97. Neuroprotective Effects and Mechanisms of Senegenin, an Effective Compound Originated From the Roots of Polygala Tenuifolia
    Zhe Chen, Yang Yu, Ying Han, Xijun Wang · 2022 · Frontiers in Pharmacology
  98. Promising Targets for the Treatment of Neurodegenerative Diseases
    Samantha Budd Haeberlein, TJR Harris · 2015 · Clinical Pharmacology & Therapeutics
  99. Dihydroquinoline Carbamate Derivatives as “Bio-oxidizable” Prodrugs for Brain Delivery of Acetylcholinesterase Inhibitors: [11C] Radiosynthesis and Biological Evaluation
    Pierre Bohn, Fabienne Gourand, Cyril A. Papamicaël, Méziane Ibazizène, Martine Dhilly, Vincent Gembus, Florent Allix, Mihaela-Liliana Ţînţaş, Francis Marsais, Louisa Barré et al. · 2015 · ACS Chemical Neuroscience
  100. Kororamides, Convolutamines, and Indole Derivatives as Possible Tau and Dual-Specificity Kinase Inhibitors for Alzheimer’s Disease: A Computational Study
    Laura Llorach-Parés, Alfons Nonell‐Canals, Conxita Àvila, Melchor Sánchez-Martínez · 2018 · Marine Drugs